⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FBLG News
FibroBiologics, Inc. Common Stock
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
globenewswire.com
FBLG
Form 8-K
sec.gov
FBLG
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
globenewswire.com
FBLG
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
prnewswire.com
FBLG
MESO
LGVN
FATE
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
globenewswire.com
FBLG
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
globenewswire.com
FBLG
FibroBiologics to Present at the BIO Investment & Growth Summit
globenewswire.com
FBLG
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
FBLG
Form 8-K
sec.gov
FBLG
FibroBiologics Granted Extension by Nasdaq to Regain Compliance
globenewswire.com
FBLG